Testing effectiveness (Phase 2)Study completedNCT01992159
What this trial is testing
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
Who this might be right for
Postmenopausal Osteoporosis (PMO)
Amgen 252